SHENZHEN SHUNWEI CROSS BORDER INDUSTRY CO., LTD – Trademark Portfolio

Entity Type: 16

SHENZHEN SHUNWEI CROSS BORDER INDUSTRY CO., LTD holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include AOIFE. The owner is based in SHENZHEN.

404, NO. 2, DONGQI LANE, BUXIN SECOND

SHENZHEN 518000 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

AOIFE
AOIFE
Registered 2020

Trademark Classifications

SHENZHEN SHUNWEI CROSS BORDER INDUSTRY CO., LTD's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does SHENZHEN SHUNWEI CROSS BORDER INDUSTRY CO., LTD have?

SHENZHEN SHUNWEI CROSS BORDER INDUSTRY CO., LTD has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does SHENZHEN SHUNWEI CROSS BORDER INDUSTRY CO., LTD file in?

SHENZHEN SHUNWEI CROSS BORDER INDUSTRY CO., LTD files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are SHENZHEN SHUNWEI CROSS BORDER INDUSTRY CO., LTD's most well-known trademarks?

SHENZHEN SHUNWEI CROSS BORDER INDUSTRY CO., LTD's registered trademark portfolio includes well-known marks such as AOIFE. These are among 1 currently registered trademark in the portfolio.

What is SHENZHEN SHUNWEI CROSS BORDER INDUSTRY CO., LTD's trademark registration success rate?

SHENZHEN SHUNWEI CROSS BORDER INDUSTRY CO., LTD has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.